O n March 1st, engineer Zakwan Ahmad launched his concept for "The One Smart AI Pen" on Kickstarter, debuting a device that looks on a surface level like a standard ballpoint pen ...

Biogen and Eisai said the European Medicines Agency's Committee for Medicinal Products for Human Use has reaffirmed its recommended approval of their Alzheimer's drug Leqembi. The companies on ...

For Eisai and Biogen, the CHMP’s decision to stick by its previous call now punts the final approval verdict for Leqembi back to the European Commission (EC), which is the ultimate authority on ...

NEW YORK – The European Commission will resume its review of Eisai and Biogen's marketing authorization application for their anti-amyloid Alzheimer's disease drug Leqembi (lecanemab), the companies ...

Leqembi (lecanemab-irmb) is a brand-name drug prescribed to treat Alzheimer’s disease in adults with mild cognitive impairment or mild dementia. The drug comes as an intravenous (IV) infusion ...

We list the best AI writers, to make it simple and easy to create simple automated text content. The word "AI" has been named the word of the year. ChatGPT has made waves since its introduction in ...

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a... Did a new Alzheimer's drug keep this patient's ...

In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.